Treatments & Interventions
Hydralazine hydrochloride
substance
Alprostadil
substance
Sildenafil citrate
substance
Epoprostenol sodium
substance
Epoprostenol
substance
Sildenafil
substance
Bosentan
substance
Treprostinil sodium
substance
Hydralazine
substance
Nitroglycerin
substance
Iloprost
substance
Tadalafil
substance
Ambrisentan
substance
Treprostinil
substance
Macitentan
substance
Riociguat
substance
Selexipag
substance
Bosentan monohydrate
substance
Bosentan anhydrous
substance
Clinical Trials
Recent Trials
A Deep-Learning-Enabled Electrocardiogram for Detecting Pulmonary Hypertension
Natural History of Sickle Cell Disease
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension
Research Evidence
Peer-reviewed studies linked via MeSH term "Hypertension, Pulmonary" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Related Conditions
Quick Facts
- SNOMED CT
- 70995007
- UMLS CUI
- C0020542
- Fully Specified Name
- Pulmonary hypertension (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Known Treatments
- 19
- Clinical Trials
- 55
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.